An Antimetastatic Study of Arg-Asp (RD) on Salivary Adenoid Cystic Carcinoma in Vivo

Fenghe Li,Guangyan Yu,Shenglin Li,Shiqi Peng,Jia Fu,Dengcheng Wu
DOI: https://doi.org/10.3760/j.issn:1002-0098.2002.02.003
2002-01-01
Abstract:OBJECTIVE:To test the antimetastatic effects of Arg-Asp (RD) on salivary adenoid cystic carcinoma (SACC-LM) in vivo.METHODS:RD was administered orally to experimental metastasized nude mice. The pulmonary metastatic foci number and survival were determined to assay the antimetastatic effects of RD.RESULTS:30 mg/kg, 120 mg/kg of RD demonstrated an inhibitory effect on the pulmonary metastatic foci formation. All of the tested dosages (7.5 mg/kg, 30 mg/kg, 120 mg/kg) of RD prolonged the survival.CONCLUSIONS:Oral administration of RD has a antimetastatic effect on SACC-LM. RD is low toxicity.
What problem does this paper attempt to address?